Dublin, Aug. 29, 2025 (GLOBE NEWSWIRE) -- The "Lateral Flow Assays Market by Product (Kits, Readers), Application (STI, HEP, TB, Cardiac Marker, Pregnancy, Drug Abuse, Food Safety), Sample (Blood, ...

The global Lateral Flow Assay Components Market, valued at US$378.4 million in 2024, stood at US$392.4 million in 2025 and is ...

PRNewswire/ -- "The Lateral Flow Assays Market Size was US$ 7.51 billion in 2024, with a rise of US$ 7.50 billion in 2024, ...

AUSTIN, Texas and TOKYO, Sept. 9, 2025 /PRNewswire/ -- "The Lateral Flow Assays Market Size was US$ 7.51 billion in 2024, with a rise of US$ 7.50 billion in 2024, and is expected ...

The Canadian company is also working to increase utilization of its point-of-care infectious disease assays, such as tests for HIV and syphilis.

A new prototype blood test for infectious diseases, designed to be delivered and analyzed at the point of care, has the potential to save lives across the developing world. Research from Abertay ...

Shares in 4D Medical have soared up to 33%, after the US FDA approved the company's CT:VQ lung imaging test for ventilation perfusion.

IPO candidate Nexsen hopes to revolutionise the market for real-time diagnostic testing, whilst eyeing fast-track FDA ...

Microfluidic biosensors revolutionize diagnostics, providing portable, high-sensitivity tests for cancer and infections on ...

With diminished valuations but an unabated will to survive, pandemic-era 'hero' stocks have found other roads to follow. ... Read More The post Biocurious: Five years post-pandemic, the Covid ‘hero’ ...

The global antibody testing market is projected to grow at a CAGR of 6% from 2025 to 2030, driven by the rising prevalence of ...